ET has seen the minutes of the SEC meeting. Reuters. Two Indian pharmaceutical companies have sought permission from India's drug regulator to continue phase ...
Read more: Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravir ...